Reductions in commuting mobility correlate with geographic differences in SARS-CoV-2 prevalence in New York City.

Author(s): Kissler SM, Kishore N, Prabhu M, Goffman D, Beilin Y, Landau R, Gyamfi-Bannerman C, Bateman BT, Snyder J, Razavi AS, Katz D, Gal J, Bianco A, Stone J, Larremore D, Buckee CO, Grad YHJournal: Nat CommunPMID: 32938924 September 2020
SARS-CoV-2-related mortality and hospitalizations differ substantially between New York City neighborhoods. Mitigation efforts require knowing the extent to which these…

Reply to Hasford and to Spinola et al.

Author(s): Eyal N, Lipsitch M, Smith PGJournal: J Infect DisPMID: 32845306 August 2020
We proposed human challenge trials (HCTs) as a possible alternative or complement to conventional phase 3 trials for expedited severe…